Analgesics in Australia

Analgesics in Australia


The decision by the Therapeutic Goods Administration (TGA) to reduce the maximum size of packs for various acetaminophen products remains the key trend within analgesics in Australia in 2024. Announced in May 2023, the TGA has given manufacturers and retailers until February 2025 to adjust to the new measures, which have been driven by the need for a harm reduction approach to curb the high rates of intentional acetaminophen overdose in Australia. According to the TGA, approximately 225 people a...

Euromonitor International's Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Analgesics in Australia
Euromonitor International
September 2024
List Of Contents And Tables
ANALGESICS IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Manufacturers and retailers respond to TGA decision to reduce acetaminophen pack sizes
Consumer demand for “natural” products drives NPD within adult acetaminophen and topical analgesics/anaesthetic
Marketing agenda within analgesics offers a wide scope for consumer engagement
PROSPECTS AND OPPORTUNITIES
Potential disruption to distribution landscape with proposed merger of Chemist Warehouse and Sigma Healthcare
Chronic conditions likely to further drive consumption of analgesics with stronger doses or target specific pain as population ages
Greater opportunities to leverage analgesics sales with Rx co-purchases
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2019-2024
Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN AUSTRALIA
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2019-2024
Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings